← Eichor
Study identifier: NCT07191327 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Testing Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) as a Treatment of Posterior Cortical Atrophy

Condition: Posterior Cortical Atrophy  ·  Sponsor: University of Michigan

PhaseNA
Planned participants50
Who can joinAll sexes, 50 Years to no upper limit
Healthy volunteersNo

About this study

This study is being completed to learn if high-definition transcranial direct current stimulation (HD-tDCS) has an effect on visual and thinking abilities in persons with posterior cortical atrophy (PCA). Participants will be randomized to receive real or sham HD-tDCS (8 sessions over 4 days). Following the randomized treatment, participants will have optional open-label phase with real HD-tDCS up to 26 weeks and other possible testing.

This description comes directly from the study's public registry record.

Talk to the study team

Stephen Schlaefflin, BS  ·  734-936-7360  ·  schlst@umich.edu

Eileen Robinson, RN-BC  ·  734-763-1356  ·  robinsoe@umich.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MichiganAnn Arbor, Michigan, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07191327